0/118 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
Low-probability matches (unlikely to be authored by this person)
2020 Mehrbod P, Hudy D, Shyntum D, Markowski J, Łos MJ, Ghavami S. Quercetin as a Natural Therapeutic Candidate for the Treatment of Influenza Virus. Biomolecules. 11. PMID 33374214 DOI: 10.3390/biom11010010  0.01
2020 Hudecki A, Wolany W, Likus W, Markowski J, Wilk R, Kolano-Burian A, Łuczak K, Zorychta M, Kawecki M, Łos MJ. Orbital reconstruction - applied materials, therapeutic agents and clinical problems of restoration of defects. European Journal of Pharmacology. 892: 173766. PMID 33249074 DOI: 10.1016/j.ejphar.2020.173766  0.01
2020 Ahmadi M, Amiri S, Pecic S, Machaj F, Rosik J, Łos MJ, Alizadeh J, Mahdian R, da Silva Rosa SC, Schaafsma D, Shojaei S, Madrakian T, Zeki AA, Ghavami S. Pleiotropic effects of statins: A focus on cancer. Biochimica Et Biophysica Acta. Molecular Basis of Disease. 1866: 165968. PMID 32927022 DOI: 10.1016/J.Bbadis.2020.165968  0.01
2020 Drożdżal S, Rosik J, Lechowicz K, Machaj F, Kotfis K, Ghavami S, Łos MJ. FDA approved drugs with pharmacotherapeutic potential for SARS-CoV-2 (COVID-19) therapy. Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy. 53: 100719. PMID 32717568 DOI: 10.1016/j.drup.2020.100719  0.01
2020 Hybiak J, Jankowska K, Machaj F, Rosik J, Broniarek I, Żyluk A, Hilderman GC, Małecki A, Łos MJ, Urasińska E. Reprogramming and transdifferentiation - two key processes for regenerative medicine. European Journal of Pharmacology. 882: 173202. PMID 32562801 DOI: 10.1016/j.ejphar.2020.173202  0.01
2020 Sureda A, Alizadeh J, Nabavi SF, Berindan-Neagoe I, Cismaru CA, Jeandet P, Łos MJ, Clementi E, Nabavi SM, Ghavami S. Endoplasmic reticulum as a potential therapeutic target for covid-19 infection management? European Journal of Pharmacology. 882: 173288. PMID 32561291 DOI: 10.1016/j.ejphar.2020.173288  0.01
2020 Mazhari S, Gitiara A, Baghaei K, Hatami B, Rad RE, Asadirad A, Joharchi K, Tokhanbigli S, Hashemi SM, Łos MJ, Aghdaei HA, Zali MR, Ghavami S. Therapeutic potential of bone marrow-derived mesenchymal stem cells and imatinib in a rat model of liver fibrosis. European Journal of Pharmacology. 173263. PMID 32535098 DOI: 10.1016/j.ejphar.2020.173263  0.01
2020 Sharifzad F, Mardpour S, Mardpour S, Fakharian E, Taghikhani A, Sharifzad A, Kiani S, Heydarian Y, Łos MJ, Azizi Z, Ghavami S, Hamidieh AA, Ebrahimi M. HSP70/IL-2 Treated NK Cells Effectively Cross the Blood Brain Barrier and Target Tumor Cells in a Rat Model of Induced Glioblastoma Multiforme (GBM). International Journal of Molecular Sciences. 21. PMID 32218162 DOI: 10.3390/ijms21072263  0.01
2020 Hashemi M, Bahari G, Markowski J, Małecki A, Łos MJ, Ghavami S. Correction: Association of PDCD6 polymorphisms with the risk of cancer: Evidence from a meta-analysis. Oncotarget. 11: 893. PMID 32180902 DOI: 10.18632/oncotarget.27483  0.01
2020 Chaabane W, Ghavami S, Małecki A, Łos MJ. Correction to: Human Gyrovirus-Apoptin Interferes with the Cell Cycle and Induces G2/M Arrest Prior to Apoptosis. Archivum Immunologiae Et Therapiae Experimentalis. 68: 7. PMID 32078055 DOI: 10.1007/s00005-020-00570-w  0.01
2019 Soleimani Asl S, Bergen H, Ashtari N, Amiri S, Łos MJ, Mehdizadeh M. Pelargonidin exhibits restoring effects against amyloid β-induced deficits in the hippocampus of male rats. Medical Journal of the Islamic Republic of Iran. 33: 135. PMID 32280641 DOI: 10.34171/mjiri.33.135  0.01
2019 Hashemi M, Sarabandi S, Karami S, Śmieja J, Moazeni-Roodi A, Ghavami S, Łos MJ. LMO1 polymorphisms and the risk of neuroblastoma: Assessment of meta-analysis of case-control studies. Journal of Cellular and Molecular Medicine. 24: 1160-1168. PMID 31830377 DOI: 10.1111/jcmm.14836  0.01
2019 Sharifzad F, Yasavoli-Sharahi H, Mardpour S, Fakharian E, Nikuinejad H, Heydari Y, Mardpour S, Taghikhani A, Khellat R, Vafaei S, Kiani S, Ghavami S, Łos M, Noureddini M, Ebrahimi M, et al. Neuropathological and genomic characterization of glioblastoma-induced rat model: How similar is it to humans for targeted therapy? Journal of Cellular Physiology. 234: 22493-22504. PMID 31120149 DOI: 10.1002/jcp.28813  0.01
2019 Kitala D, Klama-Baryła A, Misiuga M, Łabuś W, Kraut M, Szapski M, Lesiak M, Krakowian D, Sieroń AL, Łos MJ, Kucharzewski M. Heterogeneous Mixture of Amniotic Cells is Likely a Better Source of Stem Cells than Adipose Tissue. Archivum Immunologiae Et Therapiae Experimentalis. 67: 189-196. PMID 30989240 DOI: 10.1007/s00005-019-00538-5  0.01
2019 Sharifzad F, Ghavami S, Mardpour S, Mollapour M, Azizi Z, Taghikhani A, Łos MJ, Verdi J, Fakharian E, Ebrahimi M, Hamidieh AA. Glioblastoma cancer stem cell biology: Potential theranostic targets. Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy. 42: 35-45. PMID 30877905 DOI: 10.1016/j.drup.2018.03.003  0.01
2019 Kitala D, Klama-Baryła A, Łabuś W, Ples M, Misiuga M, Kraut M, Szapski M, Bobiński R, Pielesz A, Łos MJ, Kucharzewski M. Amniotic cells share clusters of differentiation of fibroblasts and keratinocytes, influencing their ability to proliferate and aid in wound healing while impairing their angiogenesis capability. European Journal of Pharmacology. 854: 167-178. PMID 30826324 DOI: 10.1016/j.ejphar.2019.02.043  0.01
2019 Hudecki A, Łyko-Morawska D, Likus W, Skonieczna M, Markowski J, Wilk R, Kolano-Burian A, Maziarz W, Adamska J, Łos MJ. Composite Nanofibers Containing Multiwall Carbon Nanotubes as Biodegradable Membranes in Reconstructive Medicine. Nanomaterials (Basel, Switzerland). 9. PMID 30621188 DOI: 10.3390/nano9010063  0.01
2018 Wcisło-Dziadecka D, Simka K, Kaźmierczak A, Kruszniewska-Rajs C, Gola J, Grabarek B, Hybiak J, Grillon C, Mazurek U, Łos MJ. Psoriasis Treatment Changes the Expression Profile of Selected Caspases and their Regulatory MicroRNAs. Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology. 50: 525-537. PMID 30308514 DOI: 10.1159/000494166  0.01
2018 Hashemi M, Bahari G, Tabasi F, Markowski J, Małecki A, Ghavami S, Łos MJ. LAPTM4B gene polymorphism augments the risk of cancer: Evidence from an updated meta-analysis. Journal of Cellular and Molecular Medicine. 22: 6396-6400. PMID 30255662 DOI: 10.1111/jcmm.13896  0.01
2018 Hashemi M, Bahari G, Markowski J, Małecki A, Łos MJ, Ghavami S. Association of PDCD6 polymorphisms with the risk of cancer: Evidence from a meta-analysis. Oncotarget. 9: 24857-24868. PMID 29872511 DOI: 10.18632/oncotarget.25324  0.01
2017 Skubis A, Gola J, Sikora B, Hybiak J, Paul-Samojedny M, Mazurek U, Łos MJ. Impact of Antibiotics on the Proliferation and Differentiation of Human Adipose-Derived Mesenchymal Stem Cells. International Journal of Molecular Sciences. 18. PMID 29186789 DOI: 10.3390/ijms18122522  0.01
2017 Cieślar-Pobuda A, Knoflach V, Ringh MV, Stark J, Likus W, Siemianowicz K, Ghavami S, Hudecki A, Green JL, Łos MJ. Transdifferentiation and reprogramming: Overview of the processes, their similarities and differences. Biochimica Et Biophysica Acta. PMID 28460880 DOI: 10.1016/j.bbamcr.2017.04.017  0.01
2017 Chaabane W, Ghavami S, Małecki A, Łos MJ. Human Gyrovirus-Apoptin Interferes with the Cell Cycle and Induces G2/M Arrest Prior to Apoptosis. Archivum Immunologiae Et Therapiae Experimentalis. 65: 545-552. PMID 28386695 DOI: 10.1007/s00005-017-0464-8  0.01
2017 Mokarram P, Albokashy M, Zarghooni M, Moosavi MA, Sepehri Z, Chen QM, Hudecki A, Sargazi A, Alizadeh J, Moghadam AR, Hashemi M, Movassagh H, Klonisch T, Owji AA, Łos MJ, et al. New frontiers in the treatment of colorectal cancer: Autophagy and the unfolded protein response as promising targets. Autophagy. 1-39. PMID 28358273 DOI: 10.1080/15548627.2017.1290751  0.01
2017 Sherrell PC, Cieślar-Pobuda A, Ejneby MS, Sammalisto L, Gelmi A, de Muinck E, Brask J, Łos MJ, Rafat M. Rational Design of a Conductive Collagen Heart Patch. Macromolecular Bioscience. 17. PMID 28322510 DOI: 10.1002/Mabi.201600446  0.01
2016 Moosavi MA, Sharifi M, Ghafary SM, Mohammadalipour Z, Khataee A, Rahmati M, Hajjaran S, Łos MJ, Klonisch T, Ghavami S. Photodynamic N-TiO Nanoparticle Treatment Induces Controlled ROS-mediated Autophagy and Terminal Differentiation of Leukemia Cells. Scientific Reports. 6: 34413. PMID 27698385 DOI: 10.1038/srep34413  0.01
2016 Boekhout AH, Gietema JA, Milojkovic Kerklaan B, van Werkhoven ED, Altena R, Honkoop A, Los M, Smit WM, Nieboer P, Smorenburg CH, Mandigers CM, van der Wouw AJ, Kessels L, van der Velden AW, Ottevanger PB, et al. Angiotensin II-Receptor Inhibition With Candesartan to Prevent Trastuzumab-Related Cardiotoxic Effects in Patients With Early Breast Cancer: A Randomized Clinical Trial. Jama Oncology. PMID 27348762 DOI: 10.1001/Jamaoncol.2016.1726  0.01
2016 Trillsch F, Mahner S, Hilpert F, Davies L, García-Martínez E, Kristensen G, Savarese A, Vuylsteke P, Los M, Zagouri F, Gladieff L, Sehouli J, Khoon Lee C, Gebski V, Pujade-Lauraine E. Prognostic and predictive effects of primary versus secondary platinum resistance for bevacizumab treatment for platinum-resistant ovarian cancer in the AURELIA trial. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. PMID 27287207 DOI: 10.1093/annonc/mdw236  0.01
2016 Cieślar-Pobuda A, Rafat M, Knoflach V, Skonieczna M, Hudecki A, Małecki A, Urasińska E, Ghavami S, Łos MJ. Human induced pluripotent stem cell differentiation and direct transdifferentiation into corneal epithelial-like cells. Oncotarget. PMID 27275539 DOI: 10.18632/oncotarget.9791  0.01
2016 Likus W, Siemianowicz K, Bieńk K, Pakuła M, Pathak H, Dutta C, Wang Q, Shojaei S, Assaraf YG, Ghavami S, Cieślar-Pobuda A, Łos MJ. Could drugs inhibiting the mevalonate pathway also target cancer stem cells? Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy. 25: 13-25. PMID 27155373 DOI: 10.1016/j.drup.2016.02.001  0.01
2016 Gelmi A, Cieslar-Pobuda A, de Muinck E, Los M, Rafat M, Jager EW. Direct Mechanical Stimulation of Stem Cells: A Beating Electromechanically Active Scaffold for Cardiac Tissue Engineering. Advanced Healthcare Materials. PMID 27126086 DOI: 10.1002/adhm.201600307  0.01
2016 Akbari-Birgani S, Paranjothy T, Zuse A, Janikowski T, Cieślar-Pobuda A, Likus W, Urasińska E, Schweizer F, Ghavami S, Klonisch T, Łos MJ. Cancer stem cells, cancer-initiating cells and methods for their detection. Drug Discovery Today. PMID 26976692 DOI: 10.1016/J.Drudis.2016.03.004  0.01
2016 Meulendijks D, de Groot JW, Los M, Boers JE, Beerepoot LV, Polee MB, Beeker A, Portielje JE, Goey SH, de Jong RS, Vanhoutvin SA, Kuiper M, Sikorska K, Pluim D, Beijnen JH, et al. Bevacizumab combined with docetaxel, oxaliplatin, and capecitabine, followed by maintenance with capecitabine and bevacizumab, as first-line treatment of patients with advanced HER2-negative gastric cancer: A multicenter phase 2 study. Cancer. PMID 26970343 DOI: 10.1002/Cncr.29864  0.01
2016 Jain MV, Shareef A, Likus W, Cieślar-Pobuda A, Ghavami S, Łos MJ. Inhibition of miR301 enhances Akt-mediated cell proliferation by accumulation of PTEN in nucleus and its effects on cell-cycle regulatory proteins. Oncotarget. PMID 26967567 DOI: 10.18632/oncotarget.7996  0.01
2016 Klionsky DJ, Abdelmohsen K, Abe A, Abedin MJ, Abeliovich H, Acevedo Arozena A, Adachi H, Adams CM, Adams PD, Adeli K, Adhihetty PJ, Adler SG, Agam G, Agarwal R, Aghi MK, ... ... Los M, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy. 12: 1-222. PMID 26799652 DOI: 10.1080/15548627.2015.1100356  0.01
2015 Bakov VN, Los MS, Komlev DL. [FIRST EXPERIENCE OF ENTEROPLASTY OF EXTENDED URETHRAL STRICTURE. CLINICAL CASE]. Urologii︠a︡ (Moscow, Russia : 1999). 82-4. PMID 26859946  0.01
2015 Likus W, Gruszczyńska K, Markowski J, Machnikowska-Sokołowska M, Olczak Z, Bajor G, Los MJ, Baron J. Correlations between selected parameters of nasal cavity in neonates and young infants - CT study. Folia Morphologica. PMID 26711652 DOI: 10.5603/FM.a2015.0128  0.01
2015 van Vulpen JK, Velthuis MJ, Steins Bisschop CN, Travier N, van den Buijs BJ, Backx FJ, Los M, Erdkamp FL, Bloemendal HJ, Koopman M, de Roos MA, Verhaar MJ, Ten Bokkel-Huinink D, van der Wall E, Peeters PH, et al. Effects of an Exercise Program in Colon Cancer Patients Undergoing Chemotherapy. Medicine and Science in Sports and Exercise. PMID 26694846 DOI: 10.1249/MSS.0000000000000855  0.01
2015 Meulendijks D, Beerepoot LV, Boot H, de Groot JW, Los M, Boers JE, Vanhoutvin SA, Polee MB, Beeker A, Portielje JE, de Jong RS, Goey SH, Kuiper M, Sikorska K, Beijnen JH, et al. Trastuzumab and bevacizumab combined with docetaxel, oxaliplatin and capecitabine as first-line treatment of advanced HER2-positive gastric cancer: a multicenter phase II study. Investigational New Drugs. PMID 26643663 DOI: 10.1007/S10637-015-0309-4  0.01
2015 Likus W, Siemianowicz K, Markowski J, Wiaderkiewicz J, Kostrząb-Zdebel A, Jura-Szołtys E, Dziubdziela W, Wiaderkiewicz R, Łos MJ. Bacterial Infections and Osteoclastogenesis Regulators in Men and Women with Cholesteatoma. Archivum Immunologiae Et Therapiae Experimentalis. PMID 26584851 DOI: 10.1007/s00005-015-0373-7  0.01
2015 Magnusson K, Appelqvist H, Cieślar-Pobuda A, Bäck M, Kågedal B, Jonasson JA, Los MJ, Nilsson KP. An imidazole functionalized pentameric thiophene displays different staining patterns in normal and malignant cells. Frontiers in Chemistry. 3: 58. PMID 26501054 DOI: 10.3389/fchem.2015.00058  0.01
2015 Badrising SK, van der Noort V, van den Eertwegh AJ, Hamberg P, van Oort IM, van den Berg HP, Los M, Aarts MJ, Coenen JL, Gelderblom H, de Jong IJ, Kerver ED, Vrijaldenhoven S, van Voorthuizen T, Warmerdam F, et al. Prognostic parameters for response to enzalutamide after docetaxel and abiraterone treatment in metastatic castration-resistant prostate cancer patients; a possible time relation. The Prostate. PMID 26390914 DOI: 10.1002/pros.23094  0.01
2015 Shakeri R, Hosseinkhani S, Los MJ, Davoodi J, Jain MV, Cieślar-Pobuda A, Rafat M, Ardestani SK. Role of the salt bridge between glutamate 546 and arginine 907 in preservation of autoinhibited form of Apaf-1. International Journal of Biological Macromolecules. 81: 370-374. PMID 26277751 DOI: 10.1016/j.ijbiomac.2015.08.027  0.01
2015 Moghadam AR, Tutunchi S, Namvaran-Abbas-Abad A, Yazdi M, Bonyadi F, Mohajeri D, Mazani M, Marzban H, Łos MJ, Ghavami S. Pre-administration of turmeric prevents methotrexate-induced liver toxicity and oxidative stress. Bmc Complementary and Alternative Medicine. 15: 246. PMID 26199067 DOI: 10.1186/s12906-015-0773-6  0.01
2015 Shlyakhto EV, Treshkur TV, Tulintseva TE, Zhdanova ON, Tikhonenko VM, Tsurinova EA, Ilyina DY, Los MM. [Algorithm for the management of patients with ventricular arrhythmias]. Terapevticheskiĭ Arkhiv. 87: 106-12. PMID 26155628  0.01
2015 Jacobs L, Intven M, van Lelyveld N, Philippens M, Burbach M, Seldenrijk K, Los M, Reerink O. Diffusion-weighted MRI for Early Prediction of Treatment Response on Preoperative Chemoradiotherapy for Patients With Locally Advanced Rectal Cancer: A Feasibility Study. Annals of Surgery. PMID 26106836 DOI: 10.1097/SLA.0000000000001311  0.01
2015 Travier N, Velthuis MJ, Steins Bisschop CN, van den Buijs B, Monninkhof EM, Backx F, Los M, Erdkamp F, Bloemendal HJ, Rodenhuis C, de Roos MA, Verhaar M, ten Bokkel Huinink D, van der Wall E, Peeters PH, et al. Effects of an 18-week exercise programme started early during breast cancer treatment: a randomised controlled trial. Bmc Medicine. 13: 121. PMID 26050790 DOI: 10.1186/s12916-015-0362-z  0.01
2015 Oostendorp LJ, Ottevanger PB, van de Wouw AJ, Honkoop AH, Los M, van der Graaf WT, Stalmeier PF. Patients' Preferences for Information About the Benefits and Risks of Second-Line Palliative Chemotherapy and Their Oncologist's Awareness of These Preferences. Journal of Cancer Education : the Official Journal of the American Association For Cancer Education. PMID 25985960 DOI: 10.1007/s13187-015-0845-9  0.01
2015 Eichelberg C, Vervenne WL, De Santis M, Fischer von Weikersthal L, Goebell PJ, Lerchenmüller C, Zimmermann U, Bos MM, Freier W, Schirrmacher-Memmel S, Staehler M, Pahernik S, Los M, Schenck M, Flörcken A, et al. SWITCH: A Randomised, Sequential, Open-label Study to Evaluate the Efficacy and Safety of Sorafenib-sunitinib Versus Sunitinib-sorafenib in the Treatment of Metastatic Renal Cell Cancer. European Urology. 68: 837-47. PMID 25952317 DOI: 10.1016/j.eururo.2015.04.017  0.01
2015 Magnusson K, Appelqvist H, Cieślar-Pobuda A, Wigenius J, Karlsson T, Łos MJ, Kågedal B, Jonasson J, Nilsson KP. Differential vital staining of normal fibroblasts and melanoma cells by an anionic conjugated polyelectrolyte. Cytometry. Part a : the Journal of the International Society For Analytical Cytology. 87: 262-72. PMID 25605326 DOI: 10.1002/cyto.a.22627  0.01
2015 van der Sluis PC, Ubink I, van der Horst S, Boonstra JJ, Voest EE, Ruurda JP, Borel Rinkes IH, Wiezer MJ, Schipper ME, Siersema PD, Los M, Lolkema MP, van Hillegersberg R. Safety, efficacy, and long-term follow-up evaluation of perioperative epirubicin, Cisplatin, and capecitabine chemotherapy in esophageal resection for adenocarcinoma. Annals of Surgical Oncology. 22: 1555-63. PMID 25564156 DOI: 10.1245/s10434-014-4120-9  0.01
2015 Jangamreddy JR, Panigrahi S, Łos MJ. Monitoring of autophagy is complicated--salinomycin as an example. Biochimica Et Biophysica Acta. 1853: 604-10. PMID 25541282 DOI: 10.1016/j.bbamcr.2014.12.022  0.01
2015 Wissing MD, Coenen JL, van den Berg P, Westgeest HM, van den Eertwegh AJ, van Oort IM, Bos MM, Bergman AM, Hamberg P, Ten Tije AJ, Los M, Lolkema MP, de Wit R, Gelderblom H. CAST: A retrospective analysis of cabazitaxel and abiraterone acetate sequential treatment in patients with metastatic castrate-resistant prostate cancer previously treated with docetaxel. International Journal of Cancer. Journal International Du Cancer. 136: E760-72. PMID 25242736 DOI: 10.1002/ijc.29231  0.01
2015 Gelmi A, Zhang J, Cieslar-Pobuda A, Ljunngren MK, Los MJ, Rafat M, Jager EWH. Electroactive 3D materials for cardiac tissue engineering Proceedings of Spie - the International Society For Optical Engineering. 9430. DOI: 10.1117/12.2084165  0.01
2015 Rezaei Moghadam A, Hamraghani A, Khajoie Najad M, Yazdi M, Alizadeh J, Marzban H, Łos M, Ghavami S. P1132 : Regulation of oxidative stress and lipid peroxidation in methotrexate-induced liver toxicity by pretreatment with turmeric Journal of Hepatology. 62: S775-S776. DOI: 10.1016/S0168-8278(15)31329-5  0.01
2015 Eichelberg C, Vervenne WL, De Santis M, Fischer von Weikersthal L, Goebell PJ, Lerchenmüller C, Zimmermann U, Bos MMEM, Freier W, Schirrmacher-Memmel S, Staehler M, Pahernik S, Los M, Schenck M, Flörcken A, et al. SWITCH: A Randomised, Sequential, Open-label Study to Evaluate the Efficacy and Safety of Sorafenib-sunitinib Versus Sunitinib-sorafenib in the Treatment of Metastatic Renal Cell Cancer European Urology. DOI: 10.1016/j.eururo.2015.04.017  0.01
2015 Jangamreddy JR, Panigrahi S, Los MJ. Monitoring of autophagy is complicated-salinomycin as an example Biochimica Et Biophysica Acta - Molecular Cell Research. 1853: 604-610. DOI: 10.1016/j.bbamcr.2014.12.022  0.01
2015 Magnusson K, Appelqvist H, Cie?lar-Pobuda A, Wigenius J, Karlsson T, Los MJ, Kågedal B, Jonasson J, Nilsson KPR. Differential vital staining of normal fibroblasts and melanoma cells by an anionic conjugated polyelectrolyte Cytometry Part A. 87: 262-272. DOI: 10.1002/cyto.a.22627  0.01
2014 Chaabane W, Cie?lar-Pobuda A, El-Gazzah M, Jain MV, Rzeszowska-Wolny J, Rafat M, Stetefeld J, Ghavami S, Los MJ. Human-gyrovirus-Apoptin triggers mitochondrial death pathway--Nur77 is required for apoptosis triggering. Neoplasia (New York, N.Y.). 16: 679-93. PMID 25246270 DOI: 10.1016/J.Neo.2014.08.001  0.01
2014 Jangamreddy JR, Panigrahi S, Lotfi K, Yadav M, Maddika S, Tripathi AK, Sanyal S, Łos MJ. Mapping of apoptin-interaction with BCR-ABL1, and development of apoptin-based targeted therapy. Oncotarget. 5: 7198-211. PMID 25216532  0.01
2014 Rollano Peñaloza OM, Lewandowska M, Stetefeld J, Ossysek K, Madej M, Bereta J, Sobczak M, Shojaei S, Ghavami S, Łos MJ. Apoptins: selective anticancer agents. Trends in Molecular Medicine. 20: 519-28. PMID 25164066 DOI: 10.1016/J.Molmed.2014.07.003  0.01
2014 Savelyeva A, Ghavami S, Davoodpour P, Asoodeh A, Los MJ. An overview of Brevinin superfamily: structure, function and clinical perspectives. Advances in Experimental Medicine and Biology. 818: 197-212. PMID 25001538 DOI: 10.1007/978-1-4471-6458-6_10  0.01
2014 Kannan P, Los M, Los JM, Niedziolka-Jonsson J. T7 bacteriophage induced changes of gold nanoparticle morphology: biopolymer capped gold nanoparticles as versatile probes for sensitive plasmonic biosensors. The Analyst. 139: 3563-71. PMID 24898163 DOI: 10.1039/c3an02272b  0.01
2014 Lesniewski A, Los M, Jonsson-Niedzió?ka M, Krajewska A, Szot K, Los JM, Niedziolka-Jonsson J. Antibody modified gold nanoparticles for fast and selective, colorimetric T7 bacteriophage detection. Bioconjugate Chemistry. 25: 644-8. PMID 24679221 DOI: 10.1021/bc500035y  0.01
2014 Ghavami S, Sharma P, Yeganeh B, Ojo OO, Jha A, Mutawe MM, Kashani HH, Los MJ, Klonisch T, Unruh H, Halayko AJ. Airway mesenchymal cell death by mevalonate cascade inhibition: integration of autophagy, unfolded protein response and apoptosis focusing on Bcl2 family proteins. Biochimica Et Biophysica Acta. 1843: 1259-71. PMID 24637330 DOI: 10.1016/J.Bbamcr.2014.03.006  0.01
2014 Smorenburg CH, de Groot SM, van Leeuwen-Stok AE, Hamaker ME, Wymenga AN, de Graaf H, de Jongh FE, Braun JJ, Los M, Maartense E, van Tinteren H, Nortier JW, Seynaeve C. A randomized phase III study comparing pegylated liposomal doxorubicin with capecitabine as first-line chemotherapy in elderly patients with metastatic breast cancer: results of the OMEGA study of the Dutch Breast Cancer Research Group BOOG. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 25: 599-605. PMID 24504445 DOI: 10.1093/annonc/mdt588  0.01
2014 Cieślar-Pobuda A, Bäck M, Magnusson K, Jain MV, Rafat M, Ghavami S, Nilsson KPR, Los MJ. Cell type related differences in staining with pentameric thiophene derivatives Cytometry Part A. 85: 628-635. PMID 24500794 DOI: 10.1002/cyto.a.22437  0.01
2014 Wasik AM, Grabarek J, Pantovic A, Cieślar-Pobuda A, Asgari HR, Bundgaard-Nielsen C, Rafat M, Dixon IM, Ghavami S, Łos MJ. Reprogramming and carcinogenesis--parallels and distinctions. International Review of Cell and Molecular Biology. 308: 167-203. PMID 24411172 DOI: 10.1016/B978-0-12-800097-7.00005-1  0.01
2014 Badrising S, van der Noort V, van Oort IM, van den Berg HP, Los M, Hamberg P, Coenen JL, van den Eertwegh AJ, de Jong IJ, Kerver ED, van Tinteren H, Bergman AM. Clinical activity and tolerability of enzalutamide (MDV3100) in patients with metastatic, castration-resistant prostate cancer who progress after docetaxel and abiraterone treatment. Cancer. 120: 968-75. PMID 24382803 DOI: 10.1002/cncr.28518  0.01
2014 Hamaker ME, Seynaeve C, Wymenga AN, van Tinteren H, Nortier JW, Maartense E, de Graaf H, de Jongh FE, Braun JJ, Los M, Schrama JG, van Leeuwen-Stok AE, de Groot SM, Smorenburg CH. Baseline comprehensive geriatric assessment is associated with toxicity and survival in elderly metastatic breast cancer patients receiving single-agent chemotherapy: results from the OMEGA study of the Dutch breast cancer trialists' group. Breast (Edinburgh, Scotland). 23: 81-7. PMID 24314824 DOI: 10.1016/j.breast.2013.11.004  0.01
2013 Wumkes ML, van der Velden AM, Los M, Leys MB, Beeker A, Nijziel MR, van der Velden AW, Westerman M, Meerveld-Eggink A, Rimmelzwaan GF, Rijkers GT, Biesma DH. Serum antibody response to influenza virus vaccination during chemotherapy treatment in adult patients with solid tumours. Vaccine. 31: 6177-84. PMID 24176495 DOI: 10.1016/j.vaccine.2013.10.053  0.01
2013 Jain MV, Łos MJ. Spatiotemporal cytometry-simultaneous analysis of DNA replication and damage. Cytometry. Part a : the Journal of the International Society For Analytical Cytology. 83: 975-6. PMID 24124097 DOI: 10.1002/cyto.a.22399  0.01
2013 Cieślar-Pobuda A, Los MJ. Prospects and limitations of "Click-Chemistry"-based DNA labeling technique employing 5-ethynyl-2'deoxyuridine (EdU). Cytometry. Part a : the Journal of the International Society For Analytical Cytology. 83: 977-8. PMID 24115755 DOI: 10.1002/cyto.a.22394  0.01
2013 Mohan Kumar D, Yamaguchi M, Miura K, Lin M, Los M, Coy JF, Rikihisa Y. Ehrlichia chaffeensis uses its surface protein EtpE to bind GPI-anchored protein DNase X and trigger entry into mammalian cells. Plos Pathogens. 9: e1003666. PMID 24098122 DOI: 10.1371/Journal.Ppat.1003666  0.01
2013 Gerritse FL, Meulenbeld HJ, Roodhart JM, van der Velden AM, Blaisse RJ, Smilde TJ, Erjavec Z, de Wit R, Los M. Analysis of docetaxel therapy in elderly (≥70 years) castration resistant prostate cancer patients enrolled in the Netherlands Prostate Study. European Journal of Cancer (Oxford, England : 1990). 49: 3176-83. PMID 23849828 DOI: 10.1016/j.ejca.2013.06.008  0.01
2013 Meerveld-Eggink A, Bollen TL, Wijrdeman HK, Los M. [Bone metastases or an insufficiency fracture? Oncology patients reporting pain or showing bone abnormalities on a scan]. Nederlands Tijdschrift Voor Geneeskunde. 157: A6098. PMID 23841929  0.01
2013 Jangamreddy JR, Ghavami S, Grabarek J, Kratz G, Wiechec E, Fredriksson BA, Rao Pariti RK, Cieślar-Pobuda A, Panigrahi S, Łos MJ. Salinomycin induces activation of autophagy, mitophagy and affects mitochondrial polarity: differences between primary and cancer cells. Biochimica Et Biophysica Acta. 1833: 2057-69. PMID 23639289 DOI: 10.1016/j.bbamcr.2013.04.011  0.01
2013 Yeganeh B, Hashemi M, de Serres FJ, Los MJ, Ghavami S. Different faces of hepatocellular carcinoma as a health threat in 21st century. Hepatitis Monthly. 13: e9308. PMID 23613688 DOI: 10.5812/Hepatmon.9308  0.01
2013 Hashemi M, Fazaeli A, Ghavami S, Eskandari-Nasab E, Arbabi F, Mashhadi MA, Taheri M, Chaabane W, Jain MV, Łos MJ. Functional polymorphisms of FAS and FASL gene and risk of breast cancer - pilot study of 134 cases. Plos One. 8: e53075. PMID 23326385 DOI: 10.1371/journal.pone.0053075  0.01
2013 Chaabane W, User SD, El-Gazzah M, Jaksik R, Sajjadi E, Rzeszowska-Wolny J, Los MJ. Autophagy, apoptosis, mitoptosis and necrosis: interdependence between those pathways and effects on cancer. Archivum Immunologiae Et Therapiae Experimentalis. 61: 43-58. PMID 23229678 DOI: 10.1007/s00005-012-0205-y  0.01
2012 Golec P, Karczewska-Golec J, Loś M, Węgrzyn G. Novel ZnO-binding peptides obtained by the screening of a phage display peptide library. Journal of Nanoparticle Research : An Interdisciplinary Forum For Nanoscale Science and Technology. 14: 1218. PMID 23193370 DOI: 10.1007/s11051-012-1218-5  0.01
2012 Jangamreddy JR, Los MJ. Mitoptosis, a novel mitochondrial death mechanism leading predominantly to activation of autophagy. Hepatitis Monthly. 12: e6159. PMID 23087751 DOI: 10.5812/hepatmon.6159  0.01
2012 Ghavami S, Cunnington RH, Yeganeh B, Davies JJ, Rattan SG, Bathe K, Kavosh M, Los MJ, Freed DH, Klonisch T, Pierce GN, Halayko AJ, Dixon IM. Autophagy regulates trans fatty acid-mediated apoptosis in primary cardiac myofibroblasts. Biochimica Et Biophysica Acta. 1823: 2274-86. PMID 23026405 DOI: 10.1016/J.Bbamcr.2012.09.008  0.01
2012 Panigrahi S, Stetefeld J, Jangamreddy JR, Mandal S, Mandal SK, Los M. Modeling of molecular interaction between apoptin, BCR-Abl and CrkL--an alternative approach to conventional rational drug design. Plos One. 7: e28395. PMID 22253690 DOI: 10.1371/Journal.Pone.0028395  0.01
2012 Los M. Minimization and prevention of phage infections in bioprocesses. Methods in Molecular Biology (Clifton, N.J.). 834: 305-15. PMID 22144367 DOI: 10.1007/978-1-61779-483-4_19  0.01
2011 van den Heuvel PM, Los M, van Marum RJ, Jansen PA. Polypharmacy and underprescribing in older adults: rational underprescribing by general practitioners. Journal of the American Geriatrics Society. 59: 1750-2. PMID 22136537 DOI: 10.1111/j.1532-5415.2011.03548.x  0.01
2011 Alavian SM, Ande SR, Coombs KM, Yeganeh B, Davoodpour P, Hashemi M, Los M, Ghavami S. Virus-triggered autophagy in viral hepatitis - possible novel strategies for drug development. Journal of Viral Hepatitis. 18: 821-30. PMID 22093031 DOI: 10.1111/J.1365-2893.2011.01530.X  0.01
2011 Vincent FC, Los MJ. New potential instrument to fight hepatocellular cancer by restoring p53. Hepatitis Monthly. 11: 331-2. PMID 22087156  0.01
2011 Autry AE, Adachi M, Nosyreva E, Na ES, Los MF, Cheng PF, Kavalali ET, Monteggia LM. NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature. 475: 91-5. PMID 21677641 DOI: 10.1038/Nature10130  0.01
2011 Ghavami S, Mutawe MM, Sharma P, Yeganeh B, McNeill KD, Klonisch T, Unruh H, Kashani HH, Schaafsma D, Los M, Halayko AJ. Mevalonate cascade regulation of airway mesenchymal cell autophagy and apoptosis: a dual role for p53. Plos One. 6: e16523. PMID 21304979 DOI: 10.1371/Journal.Pone.0016523  0.01
2011 Meerveld-Eggink A, de Weerdt O, van der Velden AM, Los M, van der Velden AW, Stouthard JM, Nijziel MR, Westerman M, Beeker A, van Beek R, Rimmelzwaan GF, Rijkers GT, Biesma DH. Response to influenza virus vaccination during chemotherapy in patients with breast cancer. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 22: 2031-5. PMID 21303799 DOI: 10.1093/annonc/mdq728  0.01
2010 Witteveen PO, van der Mijn KJ, Los M, Kronemeijer RH, Groenewegen G, Voest EE. Phase 1/2 study of atrasentan combined with pegylated liposomal doxorubicin in platinum-resistant recurrent ovarian cancer. Neoplasia (New York, N.Y.). 12: 941-5. PMID 21076619  0.01
2010 Gökay O, Kühner D, Los M, Götz F, Bertsche U, Albert K. An efficient approach for the isolation, identification and evaluation of antimicrobial plant components on an analytical scale, demonstrated by the example of Radix imperatoriae Analytical and Bioanalytical Chemistry. 398: 2039-2047. PMID 20827467 DOI: 10.1007/s00216-010-4153-2  0.01
2010 Ghavami S, Mutawe MM, Hauff K, Stelmack GL, Schaafsma D, Sharma P, McNeill KD, Hynes TS, Kung SK, Unruh H, Klonisch T, Hatch GM, Los M, Halayko AJ. Statin-triggered cell death in primary human lung mesenchymal cells involves p53-PUMA and release of Smac and Omi but not cytochrome c. Biochimica Et Biophysica Acta. 1803: 452-67. PMID 20045437 DOI: 10.1016/j.bbamcr.2009.12.005  0.01
2010 Ghavami S, Eshragi M, Ande SR, Chazin WJ, Klonisch T, Halayko AJ, McNeill KD, Hashemi M, Kerkhoff C, Los M. S100A8/A9 induces autophagy and apoptosis via ROS-mediated cross-talk between mitochondria and lysosomes that involves BNIP3. Cell Research. 20: 314-31. PMID 19935772 DOI: 10.1038/Cr.2009.129  0.01
2009 Los M. New, exciting developments in experimental therapies in the early 21st century. European Journal of Pharmacology. 625: 1-5. PMID 19825369 DOI: 10.1016/j.ejphar.2009.10.008  0.01
2009 Los M, Schulze-Osthoff K. Catching chromatin relaxation in act by flow cytometry. Cell Cycle (Georgetown, Tex.). 8: 2140-1. PMID 19587543  0.01
2009 Ghavami S, Hashemi M, Ande SR, Yeganeh B, Xiao W, Eshraghi M, Bus CJ, Kadkhoda K, Wiechec E, Halayko AJ, Los M. Apoptosis and cancer: mutations within caspase genes. Journal of Medical Genetics. 46: 497-510. PMID 19505876 DOI: 10.1136/Jmg.2009.066944  0.01
2009 Los M, Panigrahi S, Rashedi I, Mandal S, Stetefeld J, Essmann F, Schulze-Osthoff K. Apoptin, a tumor-selective killer. Biochimica Et Biophysica Acta. 1793: 1335-42. PMID 19374922 DOI: 10.1016/J.Bbamcr.2009.04.002  0.01
2009 Ghavami S, Eshraghi M, Kadkhoda K, Mutawe MM, Maddika S, Bay GH, Wesselborg S, Halayko AJ, Klonisch T, Los M. Role of BNIP3 in TNF-induced cell death--TNF upregulates BNIP3 expression. Biochimica Et Biophysica Acta. 1793: 546-60. PMID 19321129 DOI: 10.1016/j.bbamcr.2009.01.002  0.01
2009 Los M, Maddika S, Erb B, Schulze-Osthoff K. Switching Akt: from survival signaling to deadly response. Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology. 31: 492-5. PMID 19319914 DOI: 10.1002/bies.200900005  0.01
2009 Gurevich-Panigrahi T, Panigrahi S, Wiechec E, Los M. Obesity: pathophysiology and clinical management. Current Medicinal Chemistry. 16: 506-21. PMID 19199918  0.01
2009 Alberti E, Los M, García R, Fraga JL, Serrano T, Hernández E, Klonisch T, Macías R, Martínez L, Castillo L, de la Cuétara K. Prolonged survival and expression of neural markers by bone marrow-derived stem cells transplanted into brain lesions. Medical Science Monitor : International Medical Journal of Experimental and Clinical Research. 15: BR47-54. PMID 19179961  0.01
2009 Maddika S, Panigrahi S, Wiechec E, Wesselborg S, Fischer U, Schulze-Osthoff K, Los M. Unscheduled Akt-triggered activation of cyclin-dependent kinase 2 as a key effector mechanism of apoptin's anticancer toxicity. Molecular and Cellular Biology. 29: 1235-48. PMID 19103742 DOI: 10.1128/MCB.00668-08  0.01
2008 Glogowska A, Pyka J, Kehlen A, Los M, Perumal P, Weber E, Cheng SY, Hoang-Vu C, Klonisch T. The cytoplasmic domain of proEGF negatively regulates motility and elastinolytic activity in thyroid carcinoma cells. Neoplasia (New York, N.Y.). 10: 1120-30. PMID 18813355  0.01
2008 Klonisch T, Wiechec E, Hombach-Klonisch S, Ande SR, Wesselborg S, Schulze-Osthoff K, Los M. Cancer stem cell markers in common cancers - therapeutic implications. Trends in Molecular Medicine. 14: 450-60. PMID 18775674 DOI: 10.1016/j.molmed.2008.08.003  0.01
2008 Panigrahi S, Klonisch T, Los M. The art of killing: double stroke with apoptin and survivin as a novel approach in cancer therapy. Cancer Biology & Therapy. 7: 1061-2. PMID 18698166  0.01
2008 Hombach-Klonisch S, Panigrahi S, Rashedi I, Seifert A, Alberti E, Pocar P, Kurpisz M, Schulze-Osthoff K, Mackiewicz A, Los M. Adult stem cells and their trans-differentiation potential--perspectives and therapeutic applications. Journal of Molecular Medicine (Berlin, Germany). 86: 1301-14. PMID 18629466 DOI: 10.1007/s00109-008-0383-6  0.01
2008 Hombach-Klonisch S, Paranjothy T, Wiechec E, Pocar P, Mustafa T, Seifert A, Zahl C, Gerlach KL, Biermann K, Steger K, Hoang-Vu C, Schulze-Osthoff K, Los M. Cancer stem cells as targets for cancer therapy: selected cancers as examples. Archivum Immunologiae Et Therapiae Experimentalis. 56: 165-80. PMID 18512024 DOI: 10.1007/s00005-008-0023-4  0.01
2008 Ghavami S, Asoodeh A, Klonisch T, Halayko AJ, Kadkhoda K, Kroczak TJ, Gibson SB, Booy EP, Naderi-Manesh H, Los M. Brevinin-2R(1) semi-selectively kills cancer cells by a distinct mechanism, which involves the lysosomal-mitochondrial death pathway. Journal of Cellular and Molecular Medicine. 12: 1005-22. PMID 18494941 DOI: 10.1111/j.1582-4934.2008.00129.x  0.01
2008 Maddika S, Ande SR, Wiechec E, Hansen LL, Wesselborg S, Los M. Akt-mediated phosphorylation of CDK2 regulates its dual role in cell cycle progression and apoptosis. Journal of Cell Science. 121: 979-88. PMID 18354084 DOI: 10.1242/jcs.009530  0.01
2008 Ghavami S, Rashedi I, Dattilo BM, Eshraghi M, Chazin WJ, Hashemi M, Wesselborg S, Kerkhoff C, Los M. S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway. Journal of Leukocyte Biology. 83: 1484-92. PMID 18339893 DOI: 10.1189/Jlb.0607397  0.01
2008 Sonke GS, Beerepoot LV, Los M. A patient with subdiaphragmatic air. The Netherlands Journal of Medicine. 66: 89-90. PMID 18292615  0.01
2008 Ghavami S, Kerkhoff C, Chazin WJ, Kadkhoda K, Xiao W, Zuse A, Hashemi M, Eshraghi M, Schulze-Osthoff K, Klonisch T, Los M. S100A8/9 induces cell death via a novel, RAGE-independent pathway that involves selective release of Smac/DIABLO and Omi/HtrA2. Biochimica Et Biophysica Acta. 1783: 297-311. PMID 18060880 DOI: 10.1016/J.Bbamcr.2007.10.015  0.01
2008 Maddika S, Wiechec E, Ande SR, Poon IK, Fischer U, Wesselborg S, Jans DA, Schulze-Osthoff K, Los M. Interaction with PI3-kinase contributes to the cytotoxic activity of apoptin. Oncogene. 27: 3060-5. PMID 18059340 DOI: 10.1038/sj.onc.1210958  0.01
2007 Henson ES, Johnston JB, Los M, Gibson SB. Clinical activities of the epidermal growth factor receptor family inhibitors in breast cancer. Biologics : Targets & Therapy. 1: 229-39. PMID 19707333  0.01
2007 Rashedi I, Panigrahi S, Ezzati P, Ghavami S, Los M. Autoimmunity and apoptosis--therapeutic implications. Current Medicinal Chemistry. 14: 3139-51. PMID 18220747  0.01
2007 Maddika S, Bay GH, Kroczak TJ, Ande SR, Maddika S, Wiechec E, Gibson SB, Los M. Akt is transferred to the nucleus of cells treated with apoptin, and it participates in apoptin-induced cell death. Cell Proliferation. 40: 835-48. PMID 18021174 DOI: 10.1111/j.1365-2184.2007.00475.x  0.01
Hide low-probability matches.